Transcat, Inc. (NASDAQ:TRNS) Given Consensus Recommendation of “Hold” by Brokerages

Transcat, Inc. (NASDAQ:TRNS) has been assigned an average recommendation of “Hold” from the five research firms that are presently covering the company, Marketbeat.com reports. Two equities research analysts have rated the stock with a sell recommendation, two have given a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year price target among brokers that have covered the stock in the last year is $105.3333.

TRNS has been the subject of several analyst reports. Zacks Research lowered shares of Transcat from a “hold” rating to a “strong sell” rating in a research note on Monday, April 6th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Transcat in a research note on Monday, May 4th.

Transcat Stock Down 0.6%

TRNS stock opened at $76.06 on Wednesday. The company has a current ratio of 2.21, a quick ratio of 1.85 and a debt-to-equity ratio of 0.34. Transcat has a 1 year low of $50.23 and a 1 year high of $97.08. The company has a fifty day simple moving average of $76.03 and a 200 day simple moving average of $67.88. The firm has a market cap of $709.64 million, a PE ratio of 89.48 and a beta of 0.68.

Institutional Investors Weigh In On Transcat

Several institutional investors and hedge funds have recently modified their holdings of the business. Vanguard Group Inc. lifted its position in Transcat by 0.4% during the 3rd quarter. Vanguard Group Inc. now owns 530,771 shares of the scientific and technical instruments company’s stock worth $38,852,000 after acquiring an additional 2,041 shares during the last quarter. Royce & Associates LP lifted its position in Transcat by 15.3% during the 4th quarter. Royce & Associates LP now owns 390,546 shares of the scientific and technical instruments company’s stock worth $22,156,000 after acquiring an additional 51,774 shares during the last quarter. Dimensional Fund Advisors LP lifted its position in Transcat by 3.7% during the 1st quarter. Dimensional Fund Advisors LP now owns 262,033 shares of the scientific and technical instruments company’s stock worth $19,244,000 after acquiring an additional 9,266 shares during the last quarter. Wellington Management Group LLP lifted its position in Transcat by 677.7% during the 4th quarter. Wellington Management Group LLP now owns 248,539 shares of the scientific and technical instruments company’s stock worth $14,100,000 after acquiring an additional 216,579 shares during the last quarter. Finally, Bamco Inc. NY lifted its position in Transcat by 6.2% during the 4th quarter. Bamco Inc. NY now owns 203,477 shares of the scientific and technical instruments company’s stock worth $11,543,000 after acquiring an additional 11,911 shares during the last quarter. Institutional investors and hedge funds own 98.34% of the company’s stock.

Transcat Company Profile

Transcat, Inc (NASDAQ: TRNS) is a leading provider of calibration, laboratory, and metrology services in North America. Founded in 1964 and headquartered in Ronkonkoma, New York, the company specializes in ensuring the accuracy and compliance of measurement instruments across a wide range of industries. Transcat operates a network of ISO/IEC 17025–accredited laboratories and offers on-site field calibration, instrument repair, and preventive maintenance services.

In addition to its calibration services, Transcat distributes precision instrumentation and related software solutions from top manufacturers.